In the current study, GFAP was the best biomarker for evaluating infarct volume, considering that this protein had the overall highest correlation to infarct volume, with the smallest confidence interval, throughout the whole week in this mixed ischemic stroke population with a wide range of infarct volumes. This evidence concerns the gene GFAP and ischemic stroke.